| Upcoming Revisions to USP 30–NF 25, First Supplement |
Scientific Liaison |
ONDANSETRON
USP 28
USP 28 2S, p. 3515
PF 30(6), p. 2021
Packaging and storage
|
()
|
OXYBUTYNIN CHLORIDE
USP 29–NF 24 p. 1602
PF 32(3) p. 810
Related compounds
|
()
|
PAROXETINE HYDROCHLORIDE
USP 29–NF 24 p. 1644
PF 32 (3) p. 811
Assay
|
()
|
PENTAZOCINE AND ACETAMINOPHEN TABLETS (new)
PF28(6) p. 1838
Title
Definition
Packaging and storage
USP Reference standards
Identification
Uniformity of dosage units
Assay for pentazocine
Assay for acetaminophen
|
()
|
PENTOBARBITAL SODIUM INJECTION
USP 29–NF 24 p. 1680
PF 32(2) p. 364
Identification
Assay
|
()
|
PHENYTOIN TABLETS
USP 27, p. 1479
PF29(6) p. 1965
Current Title (not to change until February 1, 2007)
PF29(6) p. 1965
New Title: Phenytoin Chewable Tablets (to become official February 1, 2007)
Definition
Packaging and storage
Labeling
USP Reference standards
Identification
Dissolution
Uniformity of dosage units
Assay
|
()
|
POLYETHYLENE OXIDE
USP 29–NF 24 p. 3398
PF 32(2) p. 398
Packaging and storage
Identification B
Limit of free ethylene oxide
Organic volatile impurities, Method I <467> (delete)
Residual solvents <467> (delete)
|
()
|
POLYISOBUTYLENE
USP 29–NF 24 p. 3399
PF 32(3) p. 828
Loss on drying <731>
|
()
|
POTASSIUM PERCHLORATE
USP 29–NF 24 p. 1775
PF 32(2) p. 364
USP Reference standards <11> (delete)
Assay
|
()
|
PREDNICARBATE CREAM (new)
PF 32(3) p. 819
Microbial limits <61>
|
()
|
PREDNICARBATE CREAM (new)
PF 32(3) p. 819
Title
Definition
Packaging and storage
USP Reference standards <11>
Identification
Consistency
Minimum fill <755>
pH <791>
Related compounds
Assay
|
()
|
PREDNICARBATE OINTMENT (new)
PF 32(3) p. 822
Microbial limits <61>
|
()
|
PREDNICARBATE OINTMENT (new)
PF 32(3) p. 822
Title
Definition
Packaging and storage
USP Reference standards <11>
Identification
Consistency
Minimum fill <755>
Related compounds
Assay
|
()
|
PREDNISOLONE SODIUM PHOSPHATE
USP 29–NF 24 p. 1791
PF 32(2) p. 365
USP Reference standards <11>
Identification A
|
()
|
PYRIDOXINE HYDROCHLORIDE INJECTION
USP 29–NF 24 p. 1870
PF 32(2) p. 369
Assay
|
()
|
QUAZEPAM TABLETS
USP 29–NF 24 p. 1875
PF 32(2) p. 370
USP Reference standards <11>
Assay
|
()
|
QUINAPRIL TABLETS
USP 28, p. 1691
PF29(4), p. 1071
Packaging and storage
|
()
|
RITONAVIR
USP 29–NF 24 1S p. 3577
PF 32(2) p. 370
Identification A
Related compounds
|
()
|
ROPIVACAINE HYDROCHLORIDE INJECTION (new)
PF 32(2) p. 374
Bacterial endotoxins <85>
Sterility <71>
|
()
|
ROPIVACAINE HYDROCHLORIDE INJECTION (new)
PF 32(2) p. 374
Title
Definition
Packaging and storage
USP Reference standards <11>
Identification A, B
Particulate matter <788>
pH <791>
Limit of 2,6-dimethylaniline (ropivacaine related compound A, base)
Enantiomeric purity
Other requirements
Assay
|
()
|
SAQUINAVIR CAPSULES
USP 29–NF 24 p. 1946
PF 32(3) p. 824
Dissolution <711>
|
()
()
|
SODIUM FLUORIDE AND PHOSPHORIC ACID TOPICAL SOLUTION
USP 29–NF 24 p. 1982
PF 32(3) p. 824
Title (delete)
Definition (delete)
Packaging and storage (delete)
Labeling (delete)
USP Reference standards <11> (delete)
pH <791> (delete)
Residual solvents <467> (delete)
Other requirements (delete)
Assay (delete)
|
()
|
SODIUM SALICYLATE TABLETS
USP 29–NF 24 2S p. 3745
PF 32(3) p. 825
Dissolution <711>
|
()
()
|
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
USP 29–NF 24 p. 2001
PF 32(2) p. 376
Dissolution <711>
|
()
()
|
